Samyook Busan Hospital Achieves 'Grade 1' in Pneumonia Evaluation for Sixth Consecutive Time, Reaffirming Medical Trust

Leading Pneumonia Management with Accurate Diagnosis and Rapid Treatment
Outstanding Score of 97.6, Far Surpassing the Average of 82.9

Samyook Busan Hospital has once again solidified its reputation for medical reliability in the region by receiving the highest rating, Grade 1, for the sixth consecutive time in the pneumonia adequacy evaluation conducted by the Health Insurance Review & Assessment Service (HIRA).

According to the hospital on July 21, this evaluation was conducted from October 2023 to March 2024, targeting 599 medical institutions nationwide. The assessment focused on the appropriateness of initial diagnosis and antibiotic treatment for adult patients hospitalized with pneumonia.

In this evaluation, Samyook Busan Hospital achieved excellent results in all five key indicators: oxygen saturation testing, use of severity assessment tools, prescription of sputum culture tests, whether blood culture tests were performed prior to antibiotics, and the rate of antibiotic administration within eight hours. The hospital received a comprehensive score of 97.6 points, significantly exceeding the overall average of 82.9 points.

Choi Myungseop, director of the hospital, stated, "Pneumonia is a particularly fatal infectious disease for the elderly or those with chronic illnesses. Since rapid diagnosis and treatment are directly linked to saving lives, we will continue to strengthen our infection control and patient-centered care systems."

Samyook Busan Hospital has also been focusing on enhancing its infectious disease response capabilities, improving medical accessibility within the local community, and establishing standardized clinical processes, thereby continuously reinforcing its role as a public medical institution.

Perspective view of Samyook Busan Hospital expansion.

This content was produced with the assistance of AI translation services.